ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Markets/EquitiesArticle

AI-driven stock-picking model posts 185% return, highlights top picks

An AI-powered investment model has outperformed the S&P 500 by 104 percentage points since late 2023, with recent stock picks including Haemonetics and Merck gaining double digits in August alone.

PA
Priya Anand · Equities & Earnings Desk · 24 Aug 2026 · 23:43 · 2 min read
Share
AI-driven stock-picking model posts 185% return, highlights top picks

An artificial-intelligence-driven stock selection system has delivered a 184.93% total return since its November 2023 launch, surpassing the S&P 500 by 104.28 percentage points, according to InvestingPro’s ProPicks model.

The system evaluates more than 60,000 stocks globally using 15 years of financial data across 150 quantitative models to identify up to 20 high-conviction positions per strategy. While U.S. equities were mixed on the day, the AI’s recent selections posted outsized gains in August, with Haemonetics Corporation leading domestic gains at +26.72% for the month and +98.75% since selection in September 2025.

Haemonetics reported first-quarter 2027 revenue of $339.4 million and adjusted earnings per share of $1.14, beating consensus forecasts of $1.10 versus a $1.01 expectation. The company raised its full-year revenue growth guidance to a 5%–8% range and trades at a forward price-to-earnings multiple of 14.9x. Citi upgraded the stock to Buy with a $90 price target, citing a supply agreement with CSL Plasma as a key catalyst.

Merck & Co also featured among the AI’s top performers, rising 15.71% in August and 45.23% since being identified in January 2026. The pharmaceutical group reported third-quarter earnings of $2.58 per share, exceeding estimates by nearly 10%, and raised its full-year revenue guidance to $67.3 billion. Merck’s EBITDA surged 56.3% year-over-year, supported by strong momentum in its cardiovascular drug Winrevair and oncology franchise Keytruda, alongside a $9.2 billion deal with Cidara Therapeutics.

Other domestic picks posting double-digit August gains included Mativ Holdings (+40.32%), Ramaco Resources (+35.55%), Gartner (+34.27%), TPG Inc (+22.34%), Everforth (+14.28%) and SM Energy (+12.12%). Internationally, Yubico AB led gains at +40.98% in August and +109.58% since selection, followed by Indosat (+38.42%), Regional Container (+30.74%) and GS Holdings (+28.76%).

The ProPicks model has previously identified Siemens Energy and Sandisk among its top performers, with respective gains of 231.5% and 189% since selection. The service is currently available to InvestingPro subscribers for less than $8 per month under a summer promotion offering up to 55% off regular pricing.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT